Cargando…

Redefining tuberculosis: an interview with Lalita Ramakrishnan

Professor Lalita Ramakrishnan is at the forefront of modern tuberculosis (TB) research. She has developed vital tools, most notably a robust zebrafish model, to study this disease, leading to seminal discoveries uncovering bacterial and host interactions throughout infection. Her group has harnessed...

Descripción completa

Detalles Bibliográficos
Autor principal: Ramakrishnan, Lalita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Company of Biologists Ltd 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10073006/
https://www.ncbi.nlm.nih.gov/pubmed/36951140
http://dx.doi.org/10.1242/dmm.050189
_version_ 1785019498322984960
author Ramakrishnan, Lalita
author_facet Ramakrishnan, Lalita
author_sort Ramakrishnan, Lalita
collection PubMed
description Professor Lalita Ramakrishnan is at the forefront of modern tuberculosis (TB) research. She has developed vital tools, most notably a robust zebrafish model, to study this disease, leading to seminal discoveries uncovering bacterial and host interactions throughout infection. Her group has harnessed this knowledge to develop new treatments for TB and shape clinical research. By unveiling these complex interactions, they have also improved our understanding of fundamental biology of macrophages and other infectious diseases, such as leprosy.
format Online
Article
Text
id pubmed-10073006
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher The Company of Biologists Ltd
record_format MEDLINE/PubMed
spelling pubmed-100730062023-04-05 Redefining tuberculosis: an interview with Lalita Ramakrishnan Ramakrishnan, Lalita Dis Model Mech A Model for Life Professor Lalita Ramakrishnan is at the forefront of modern tuberculosis (TB) research. She has developed vital tools, most notably a robust zebrafish model, to study this disease, leading to seminal discoveries uncovering bacterial and host interactions throughout infection. Her group has harnessed this knowledge to develop new treatments for TB and shape clinical research. By unveiling these complex interactions, they have also improved our understanding of fundamental biology of macrophages and other infectious diseases, such as leprosy. The Company of Biologists Ltd 2023-03-23 /pmc/articles/PMC10073006/ /pubmed/36951140 http://dx.doi.org/10.1242/dmm.050189 Text en © 2023. Published by The Company of Biologists Ltd https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.
spellingShingle A Model for Life
Ramakrishnan, Lalita
Redefining tuberculosis: an interview with Lalita Ramakrishnan
title Redefining tuberculosis: an interview with Lalita Ramakrishnan
title_full Redefining tuberculosis: an interview with Lalita Ramakrishnan
title_fullStr Redefining tuberculosis: an interview with Lalita Ramakrishnan
title_full_unstemmed Redefining tuberculosis: an interview with Lalita Ramakrishnan
title_short Redefining tuberculosis: an interview with Lalita Ramakrishnan
title_sort redefining tuberculosis: an interview with lalita ramakrishnan
topic A Model for Life
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10073006/
https://www.ncbi.nlm.nih.gov/pubmed/36951140
http://dx.doi.org/10.1242/dmm.050189
work_keys_str_mv AT ramakrishnanlalita redefiningtuberculosisaninterviewwithlalitaramakrishnan